Literature DB >> 27789403

Induced pluripotent stem cells (iPSC) created from skin fibroblasts of patients with Prader-Willi syndrome (PWS) retain the molecular signature of PWS.

Lisa C Burnett1, Charles A LeDuc2, Carlos R Sulsona3, Daniel Paull4, Sanaa Eddiry5, Brynn Levy6, Jean Pierre Salles7, Maithe Tauber8, Daniel J Driscoll9, Dieter Egli10, Rudolph L Leibel11.   

Abstract

Prader-Willi syndrome (PWS) is a syndromic obesity caused by loss of paternal gene expression in an imprinted interval on 15q11.2-q13. Induced pluripotent stem cells were generated from skin cells of three large deletion PWS patients and one unique microdeletion PWS patient. We found that genes within the PWS region, including SNRPN and NDN, showed persistence of DNA methylation after iPSC reprogramming and differentiation to neurons. Genes within the PWS minimum critical deletion region remain silenced in both PWS large deletion and microdeletion iPSC following reprogramming. PWS iPSC and their relevant differentiated cell types could provide in vitro models of PWS.
Copyright © 2016 Michael Boutros, German Cancer Research Center, Heidelberg, Germany. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27789403      PMCID: PMC8202351          DOI: 10.1016/j.scr.2016.08.008

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  8 in total

1.  Birth prevalence of Prader-Willi syndrome in Australia.

Authors:  A Smith; J Egan; G Ridley; E Haan; P Montgomery; K Williams; E Elliott
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

2.  Human oocytes reprogram somatic cells to a pluripotent state.

Authors:  Scott Noggle; Ho-Lim Fung; Athurva Gore; Hector Martinez; Kathleen Crumm Satriani; Robert Prosser; Kiboong Oum; Daniel Paull; Sarah Druckenmiller; Matthew Freeby; Ellen Greenberg; Kun Zhang; Robin Goland; Mark V Sauer; Rudolph L Leibel; Dieter Egli
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

3.  Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome.

Authors:  Jiayin Yang; Jie Cai; Ya Zhang; Xianming Wang; Wen Li; Jianyong Xu; Feng Li; Xiangpeng Guo; Kang Deng; Mei Zhong; Yonglong Chen; Liangxue Lai; Duanqing Pei; Miguel A Esteban
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

4.  The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome.

Authors:  Yonatan Stelzer; Ido Sagi; Ofra Yanuka; Rachel Eiges; Nissim Benvenisty
Journal:  Nat Genet       Date:  2014-05-11       Impact factor: 38.330

5.  Prader-Willi syndrome.

Authors:  Suzanne B Cassidy; Daniel J Driscoll
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

6.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

7.  Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi Syndrome.

Authors:  Eric Bieth; Sanaa Eddiry; Véronique Gaston; Françoise Lorenzini; Alexandre Buffet; Françoise Conte Auriol; Catherine Molinas; Dorothée Cailley; Caroline Rooryck; Benoit Arveiler; Jérome Cavaillé; Jean Pierre Salles; Maïthé Tauber
Journal:  Eur J Hum Genet       Date:  2014-06-11       Impact factor: 4.246

Review 8.  Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.

Authors:  M A Angulo; M G Butler; M E Cataletto
Journal:  J Endocrinol Invest       Date:  2015-06-11       Impact factor: 4.256

  8 in total
  11 in total

Review 1.  Modeling rare diseases with induced pluripotent stem cell technology.

Authors:  Ruthellen H Anderson; Kevin R Francis
Journal:  Mol Cell Probes       Date:  2018-01-05       Impact factor: 2.365

Review 2.  Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular Diseases.

Authors:  Young Wook Chun; Matthew D Durbin; Charles C Hong
Journal:  Curr Cardiol Rep       Date:  2018-04-17       Impact factor: 2.931

3.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Authors:  Lisa C Burnett; Charles A LeDuc; Carlos R Sulsona; Daniel Paull; Richard Rausch; Sanaa Eddiry; Jayne F Martin Carli; Michael V Morabito; Alicja A Skowronski; Gabriela Hubner; Matthew Zimmer; Liheng Wang; Robert Day; Brynn Levy; Ilene Fennoy; Beatrice Dubern; Christine Poitou; Karine Clement; Merlin G Butler; Michael Rosenbaum; Jean Pierre Salles; Maithe Tauber; Daniel J Driscoll; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

Review 4.  Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Authors:  K R Sabitha; Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989

5.  IPSC Models of Chromosome 15Q Imprinting Disorders: From Disease Modeling to Therapeutic Strategies.

Authors:  Noelle D Germain; Eric S Levine; Stormy J Chamberlain
Journal:  Adv Neurobiol       Date:  2020

6.  Alteration of Genomic Imprinting Status of Human Parthenogenetic Induced Pluripotent Stem Cells during Neural Lineage Differentiation.

Authors:  Hye Jeong Lee; Na Young Choi; Seung-Wong Lee; Yukyeong Lee; Kisung Ko; Gwang Jun Kim; Han Sung Hwang; Kinarm Ko
Journal:  Int J Stem Cells       Date:  2019-03-30       Impact factor: 2.500

7.  Genome-wide DNA methylation analysis reveals that mouse chemical iPSCs have closer epigenetic features to mESCs than OSKM-integrated iPSCs.

Authors:  Wangfang Ping; Jian Hu; Gongcheng Hu; Yawei Song; Qing Xia; Mingze Yao; Shixin Gong; Cizhong Jiang; Hongjie Yao
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

8.  Loss of hierarchical imprinting regulation at the Prader-Willi/Angelman syndrome locus in human iPSCs.

Authors:  Duarte Pólvora-Brandão; Mariana Joaquim; Inês Godinho; Domenico Aprile; Ana Rita Álvaro; Isabel Onofre; Ana Cláudia Raposo; Luís Pereira de Almeida; Sofia T Duarte; Simão T da Rocha
Journal:  Hum Mol Genet       Date:  2018-12-01       Impact factor: 6.150

Review 9.  A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15.

Authors:  Alessia Casamassa; Daniela Ferrari; Maurizio Gelati; Massimo Carella; Angelo Luigi Vescovi; Jessica Rosati
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

10.  Functional diversity of small nucleolar RNAs.

Authors:  Tomaž Bratkovič; Janja Božič; Boris Rogelj
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.